Tenax Therapeutics annual debt-to-assets ratio
2013
2014
2015
2018
2019
2020
2021
2022
2023
Tenax Therapeutics Debt-to-Assets Ratio Growth & History (TENX)
Tenax Therapeutics's debt-to-assets ratio was 0.04 for fiscal 2023.
View full Tenax Therapeutics company overviewTenax Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 0.04 | −0.19 | −81.93% |
| 2022 | 2022-12-31 | 0.24 | 0.19 | +388.99% |
| 2021 | 2021-12-31 | 0.05 | 0.04 | +452.03% |
| 2020 | 2020-12-31 | 0.01 | −0.02 | −67.42% |
| 2019 | 2019-12-31 | 0.03 | 0.03 | — |
| 2018 | 2018-12-31 | 0.00 | — | — |
| 2015 · Apr 30 | 2015-04-30 | 0.00 | 0.00 | +5.65% |
| 2014 | 2014-04-30 | 0.00 | −1.56 | −99.92% |
| 2013 | 2013-04-30 | 1.56 | — | — |
Tenax Therapeutics quarterly debt-to-assets ratio
Q1.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.00 | 0.00 | — |
| Q1 2026 | 2026-03-31 | 0.00 | 0.00 | — |
| Q4 2025 | 2025-12-31 | 0.00 | 0.00 | — |
| Q3 2025 | 2025-09-30 | 0.00 | 0.00 | — |
| Q2 2025 | 2025-06-30 | 0.00 | 0.00 | — |
| Q1 2025 | 2025-03-31 | 0.00 | 0.00 | — |
| Q4 2024 | 2024-12-31 | 0.00 | 0.00 | — |
| Q3 2024 | 2024-09-30 | 0.00 | 0.00 | — |
| Q2 2024 | 2024-06-30 | 0.00 | 0.00 | — |
| Q1 2024 | 2024-03-31 | 0.00 | 0.00 | — |
| Q4 2023 | 2023-12-31 | 0.00 | — | — |
| Q3 2023 | 2023-09-30 | 0.00 | −0.04 | — |
| Q2 2023 | 2023-06-30 | 0.00 | −0.03 | — |
| Q1 2023 | 2023-03-31 | 0.00 | −0.07 | — |
| Q3 2022 | 2022-09-30 | 0.04 | 0.01 | +25.96% |
| Q2 2022 | 2022-06-30 | 0.03 | −0.09 | −75.76% |
| Q1 2022 | 2022-03-31 | 0.07 | 0.06 | +952.44% |
| Q4 2021 | 2021-12-31 | 0.05 | 0.04 | +452.03% |
| Q3 2021 | 2021-09-30 | 0.04 | 0.03 | +257.59% |
| Q2 2021 | 2021-06-30 | 0.12 | 0.10 | +438.06% |
| Q1 2021 | 2021-03-31 | 0.01 | −0.02 | −72.33% |
| Q4 2020 | 2020-12-31 | 0.01 | −0.02 | −67.42% |
| Q3 2020 | 2020-09-30 | 0.01 | −0.02 | −61.00% |
| Q2 2020 | 2020-06-30 | 0.02 | −0.00 | −4.93% |
| Q1 2020 | 2020-03-31 | 0.02 | 0.00 | +12.64% |
| Q4 2019 | 2019-12-31 | 0.03 | 0.03 | — |
| Q3 2019 | 2019-09-30 | 0.03 | — | — |
| Q2 2019 | 2019-06-30 | 0.02 | — | — |
| Q1 2019 | 2019-03-31 | 0.02 | — | — |
| Q4 2018 | 2018-12-31 | 0.00 | — | — |
| Q4 2015 · Apr 30 | 2015-04-30 | 0.00 | 0.00 | +5.65% |
| Q3 2015 | 2015-01-31 | 0.00 | −0.00 | −66.25% |
| Q2 2015 | 2014-10-31 | 0.00 | −0.02 | −97.90% |
| Q1 2015 | 2014-07-31 | 0.00 | −0.02 | −96.49% |
| Q4 2014 | 2014-04-30 | 0.00 | −1.56 | −99.92% |
| Q3 2014 | 2014-01-31 | 0.01 | — | — |
| Q2 2014 | 2013-10-31 | 0.02 | — | — |
| Q1 2014 | 2013-07-31 | 0.02 | −0.94 | −98.04% |
| Q4 2013 | 2013-04-30 | 1.56 | — | — |
| Q1 2013 | 2012-07-31 | 0.96 | — | — |
Tenax Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, Tenax Therapeutics's debt-to-assets ratio increased from 0.00 to 0.04, a change of 0.04. The latest reported quarter, Q2 2026, shows 0.00.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenax Therapeutics source filings ↗